You are here

Article Text

Article menu

Download PDFPDF

Electronic poster abstracts
E-095 Early Hyperglycemia Predicts Poor Outcome Despite Successful Stroke Thrombectomy
  1. K Dezse1,
  2. S Bajgur2,
  3. A Harrison3,
  4. J Mejilla4,
  5. W Hicks4,
  6. T Davis3,
  7. P Pema3,
  8. R Budzik3,
  9. N Vora3
  1. 1Ohio St. University, Columbus, OH
  2. 2Neurosurgery, University of Texas at Houston, Houston, TX
  3. 3Neuro-interventional Surgery, Riverside Methodist Hospital, Columbus, OH
  4. 4Neurology, Riverside Methodist Hospital, Columbus, OH

Abstract

Objective Our goal was to identify medical co-morbidities which negatively prognosticate outcome in stroke patients who have successful endovascular reperfusion after imaging-based selection.

Methods With approval, we retrospectively reviewed stroke interventions in the intracranial carotid and M1 middle cerebral artery at our institution over a two year period. All patients are screened for small infarcts based on a non-contrast head CT and perfusion imaging for treatment eligibility. For analysis, we included those patients with successful reperfusion only. We collected stroke risk factors, time to treatment, stroke scale, and additional medical co-morbidities: cardiomyopathy, chronic lung disease, chronic kidney disease, body mass index >30, early hyperglycemia (any 24 hour post-procedure blood sugar >150 gm/dl), history of malignancy, and dementia. These co-variates were placed into a univariate analysis to identify predictors for a poor outcome, defined as a modified Rankin Scale >2 at 90 days. Covariates with a p value of <0.2 were included in a multiple logistic regression model to identify independent predictors.

Results We analyzed 120 patients with mean age 70 (SD 13) years, median NIHSS 16, and mean time to reperfusion 408 (SD 345) minutes. Poor outcome was seen in 44 patients (37%) with mortality in 21 patients (17.5%).

After controlling for age and stroke score, early hyperglycemia was the only co-variate independently associated with poor outcome (OR 2.72, 95% CI 1.04–7.06, p = 0.04) and mortality (OR 3.18, 95% CI 1.28–7.86, p = 0.013).

Conclusions In selected stroke patients with successful endovascular reperfusion, early hyperglycemia may be independently associated with poor outcome and mortality over other medical co-morbidities. Further prospective study confirming this effect may further develop treatment strategies to prevent this injury.

Disclosures K. Dezse: None. S. Bajgur: None. A. Harrison: None. J. Mejilla: None. W. Hicks: None. T. Davis: None. P. Pema: None. R. Budzik: None. N. Vora: 2; C; Medtronic Neurovascular, Microvention Neurovascular. 3; C; Medtronic Neurovascular.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/neurintsurg-2016-012589.167

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.